| Medical and Health Sciences | 2021-2025 | 183 | US 68 | 99.96 |
| Medical Genetics | Lifetime | 215 | US 110 | 98.39 |
| Hematology | Lifetime | 257 | US 130 | 98.56 |
| Dermatology | Lifetime | 287 | US 116 | 98.18 |
| Medical Genetics | 2021-2025 | 11 | US 6 | 99.74 |
| Hematology | 2021-2025 | 26 | US 13 | 99.45 |
| Dermatology | 2021-2025 | 42 | US 12 | 99.25 |
| Oncology | 2021-2025 | 273 | US 116 | 97.59 |
| Public, Environmental and Occupational Health | 2021-2025 | 884 | US 316 | 90.99 |
| Immunology | 2021-2025 | 692 | US 248 | 78.39 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 70 | US 33 | 98.98 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 101 | US 52 | 99.10 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 154 | US 80 | 99.12 |
| Acute Myeloid Leukemia Research | Lifetime | 253 | US 129 | 99.27 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 469 | US 218 | 98.70 |
| CAR-T cell therapy research | Lifetime | 461 | US 280 | 98.65 |
| Eosinophilic Disorders and Syndromes | Lifetime | 216 | US 107 | 98.22 |
| Multiple Myeloma Research and Treatments | Lifetime | 410 | US 190 | 97.74 |
| Lymphoma Diagnosis and Treatment | Lifetime | 930 | US 403 | 97.93 |
| Acute Lymphoblastic Leukemia research | Lifetime | 641 | US 309 | 97.76 |
| Toxin Mechanisms and Immunotoxins | Lifetime | 390 | US 204 | 96.56 |
| Kruppel-like factors research | Lifetime | 194 | US 79 | 95.91 |
| Histone Deacetylase Inhibitors Research | Lifetime | 458 | US 231 | 95.92 |
| Protein Degradation and Inhibitors | Lifetime | 652 | US 319 | 95.61 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 535 | US 229 | 94.07 |
| Social Media in Health Education | Lifetime | 380 | US 206 | 90.30 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 1 | US 1 | 99.86 |
| Acute Myeloid Leukemia Research | 2021-2025 | 19 | US 14 | 99.78 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 8 | US 6 | 99.71 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 15 | US 13 | 99.65 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 56 | US 28 | 99.19 |
| CAR-T cell therapy research | 2021-2025 | 114 | US 67 | 99.26 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 21 | US 14 | 98.96 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 98 | US 48 | 98.92 |
| Kruppel-like factors research | 2021-2025 | 12 | US 6 | 98.20 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 148 | US 83 | 97.95 |
| Fungal Infections and Studies | 2021-2025 | 116 | US 35 | 96.53 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 200 | US 101 | 95.03 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 280 | US 160 | 95.60 |
| Protein Degradation and Inhibitors | 2021-2025 | 263 | US 130 | 94.48 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 104 | US 45 | 93.19 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 394 | US 179 | 93.44 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 298 | US 104 | 88.09 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 119 | US 20 | 84.70 |
| Neutropenia and Cancer Infections | 2021-2025 | 444 | US 153 | 78.72 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 414 | US 131 | 68.17 |
